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ÖZET
Amaç: Bu çalışmanın amacı romatoid artritte romatoid 
artritli (RA) hastalarda hastalık şiddeti ve süresinin böb-
rek fonksiyonları ve histopatoloji üzerine etkilerini gözle-
mektir.
Gereç ve yöntem: Çalışmaya her biri 25’er hasta içeren 
iki gruptan oluşan toplam 50 hasta alındı. Hastalık şiddeti 
sakatlık aktivite skoru (SAS) ile değerlendirildi. Tam id-
rar tetkiki, serum üre ve kretinini ve kreatinin klirensi gibi 
böbrek değişkenleri hastaneye ilk başvuruda kaydedildi. 
Aktif idrar sediment bulunan, hematuria ve/veya 300 mg/
gün’den fazla proteinürisi bulunan ve serum kreatinini 1.5 
mg/dl üzerinde olan hastalara perkutan böbrek biyopsisi 
uygulandı. 
Bulgular: Grup I hastalarda hastalık süresi 2-5 yıl ara-
sında, Grup II’de 5 yıldan uzun süreli idi. Romatoid artritli 
hastaların %28’inde idrar anormallikleri saptandı, bunla-
rın %12’sinde izole hematüri, %10’unda izole proteinüri, 
%6’sında ise hematüri ve proteinüri birlikte görüldü. Has-
taların  %14’ünde  yüksek  serum  kreatinin  değeri  (>1.5 
mg/dl)  saptandı.  Hastaların  %20’sine  böbrek  biyopsisi 
uygulandı  ve  biyopsi  sonucunda  histopatolojik  olarak 
mezanjiyal glomerülonefrit, memebranöz glomerülonefrit, 
sekonder amiloidoz ve interstisyel nefrit bulundu. Grup 
II’de ağır SAS bulunan hastaların %63’ünde idrar anor-
mallikleri saptanırken, %83’ünde artmış serum kreatinin 
ve  %60’ında  ağır  histopatolojik  anormallikler  saptandı. 
Bu durum ileri düzeyde SAS ve uzamış hastalık süresinin 
böbrek histofonksiyonel durumu üzerinde önemli etkilerle 
birlikteliğini göstermekteydi.
Sonuç: Romatoid artritte hastalık süresi ve ağırlığına pa-
ralel olarak renal fonksiyon bozukluğunda bir artış olduğu 
gözlendi. 
Anahtar kelimeler: Romatoid artrit, böbrek fonksiyonları, 
hematüri, proteinüri
ABSTRACT
Objectives: The aim of this study was to observe the ef-
fects of duration and severity of disease on renal func-
tions and histopathology in patients with rheumatoid ar-
thritis (RA).
Material and methods: The study included 50 patients 
of RA, who were divided into two groups of 25 patients 
each. Disease severity was assessed by Disability Activi-
ty Score (DAS). The renal parameters i.e., urine complete 
examination, blood urea, serum creatinine and creatinine 
clearance  were  estimated  at  enrolment.  Percutaneous 
renal biopsy was performed in patients having active uri-
nary sediment, haematuria and/or proteinuria more than 
300 mg/day and serum creatinine more than 1.5 mg/ml.
Results: Group I patients had duration of disease be-
tween 2-5 years and in Group II the duration was more 
than 5 years. Urine abnormalities were documented in 
28% RA patients and 12% patients had isolated hema-
turia, 10% patients presented with isolated proteinurea 
and combined haematuria and proteinurea was present 
in 6% patients.14% patients presented with raised crea-
tinine( >1.5mg/ml). Renal biopsy was performed in 20% 
of patients which showed mesangial glomerulonephritis, 
membranous glomerulonephritis, secondary amyloidosis 
and interstitial nephritis. In group I severe DAS score was 
present in 17% of the patient having urinary abnormality, 
however 20% patients showed histopathological findings. 
In group II 63% of patients with severe DAS score had 
urinary abnormality, 83% showed raised serum creatinine 
and 60% had histopathological abnormalities indicating 
severe DAS score and increased duration of disease was 
associated with significant effects on histofunctional sta-
tus of kidney.
Conclusion: There was a significant increase in renal 
dysfunction with duration and severity of disease in rheu-
matoid arthritis. 
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INTRODUCTION
Renal disease is a well recognised cause of ill health 
and  death  in  patients  with  Rheumatoid  arthritis 
(RA). Two broad categories of renal involvement 
occur in such patients: The first being attributed to 
the disease itself i.e. secondary amyloidosis, me-
sangial glomerulonephritis, membranous glomeru-
lonephritis, renal vasculitis and interstitial nephritis. 
Second is due to nephrotoxicity from drugs used for 
treatment of arthritis i.e. Non-steroidal anti-inflam-
matory  drugs  (NSAID’s)  and  Disease  modifying 
anti rheumatic drugs (DMARD’s) especially gold 
and penicillamine.1 The secondary amyloidosis may 
present with proteinuria, nephrotic syndrome or re-
nal impairment. The various types of glomerulone-
phritis may present with isolated hematuria, isolated 
proteinuria or combined hematuria and proteinuria.
The etiopathogenesis of renal involvement in 
RA patients is less clearly understood; however a 
high prevalence of renal impairment with evidence 
of reduced glomerular filtration rate (GFR) and tu-
bular dysfunction in RA patients is well document-
ed.2 When renal involvement in connective tissue 
disease is described, traditionally the focus has been 
on systemic lupus erythematosis, however, renal in-
volvement in RA continues to be one of the impor-
tant causes of mortality next only to cardiovascular 
disease and infections. 3
The diagnostic importance of early detection 
and etiopathogenesis of renal involvement in RA 
patients is self explanatory, as approach towards the 
management will differ with each. Therefore, the 
present study has been planned to study the histo-
functional status of kidney in patients of Rheuma-
toid arthritis.
MATERIALS AND METHODS
The present prospective cross sectional study was 
conducted on fifty adult patients of RA diagnosed 
as per the American College of Rheumatology 1987 
revised criteria4 from Rheumatology and Medicine 
department of Pt.BD Sharma PGIMS, Rohtak (In-
dia) who were already on follow up and receiving 
treatment. 
Patients  with  chronic  systemic  diseases  like 
chronic  liver  disease,  congestive  cardiac  failure, 
diabetes mellitus and hypertension were excluded. 
Similarly, moribund patients and patients with any 
other disease causing renal dysfunction were also 
excluded from the study group.
Written informed consent was taken prior to 
enrolment in the study from each patient. All pa-
tients were subjected to detailed history, clinical ex-
amination and investigations with special reference 
to renal functions. The patients were divided into 
two groups (I and II) of twenty five patients each 
depending upon duration of RA. 
Group I – patients having RA of more than 2 
years but less than 5 years duration (2-5 yrs).
Group II – patients having RA of more than 5 
years duration.
Baseline values of Blood urea, Serum creati-
nine,  urine  complete  examination  and  creatinine 
clearance were estimated in all patients, irrespective 
of group.
The proteinuria was assessed by Ames dipstick 
test and 1+ or greater (albumin >250 mg/l) was in-
terpreted as abnormal. Hematuria was defined as the 
presence of ≥5 red blood cells per high power field 
under  microscopic  examination.  The  creatinine 
clearance was measured by Cock-croft Gault for-
mula.5 Specific investigation i.e., percutaneous renal 
biopsy was performed after obtaining an informed 
consent in patients having active urinary sediments, 
haematuria and/or proteinuria more than 300 mg/
day and serum creatinine >1.5 mg % irrespective of 
the group. Renal biopsy specimen were subjected 
to light microscopy using hemotoxylin & eosin, pe-
riodic acid, congo red Schiff, gomori methnamine 
silver stains and immunoflorescence studies. All pa-
tients included in the study were evaluated for their 
disease activity by modified DAS scores (disability 
activity score).6
Calculation of DAS 28 involves four variables 
and was calculated as per following equation:
DAS 28 = 0.50 TJC* + 0.28 SJC* + 0.70 Log 
ESR*** + GH 0.014**** where
* TJC is tender joint count
** SJC is swollen joint count
*** Log erythrocyte sediment rate
**** GH is global health status of patients as 
assessed by visual analogue scale.
DAS score involves 28 specific joints including 
shoulder, elbow, wrist, MCP, PIP and knee joints.H.K. Aggarwal et al. Histofunctional status of kidney in rheumatoid arthritis 377
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Based on DAS, patients score of >5.1 indicate 
high disease activity, score of <3.2 indicate low dis-
ease activity and score of <2.6 indicates patient in 
remission
Statistical Analysis
The data obtained was subjected to standard sta-
tistical analysis. The continuous variables were re-
corded as Mean+1SD. Students t test and chi square 
tests were used for comparison of various values 
between two groups.
RESULTS
The study included fifty patients, 25 in each group. 
Majority of patients were female (84%) (Table 1). 
The age range of the patients were 23-58 years in 
group I (43.4±9.2 ) and 34-68 years in group II ( 
51.04 ±10.7). The mean hemoglobin in group I was 
10.2 ± 1.2 gm % while in group II it was 9.01± 1.36 
gm % which was statistically significant (<0.001). 
Anemia was present in both groups but more com-
mon in group II. The mean value of blood urea in 
group I was 29.00±14.41mg% and in group II was 
46.04±27.90mg%. The mean value of serum crea-
tinine in group I was 0.94±0.68mg% and in group 
II  it  was  1.90±2.27mg%.  There  was  statistically 
significant difference in values of blood urea and 
serum  creatinine  between  two  groups. The  mean 
value of GFR in group I was 104.81±27.04ml/min 
and in group II was 90.31±46.77ml/min. There was 
statistically  significant  difference  in  GFR  values 
between two groups (Table 2). Renal dysfunction 
i.e., increased blood urea, increased serum creati-
nine and decreased creatinine clearance was present 
in 4% of patients in group I and 24% of patients 
in group II, which indicated significant increase in 
renal dysfunctions in group II patients who had in-
creased duration of disease (Table 3).
Isolated  haematuria  was  present  in  12%  of 
patients each in group I and II. Similarly, isolated 
proteinuria was present in 8% of patients in group I 
and 12 % of patients in group II, whereas combined 
haematuria and proteinuria was present in 4 % of 
patients in group I and 8% of the patients in Group 
II (Table 4).
Twenty  four  hour  urinary  protein  more  than 
2.5 g/day was present in 16% of patients in group 
II as compared to 8% of patients in group I. Protei-
nuria in the range of 0.3 to 2.5gms/day was present 
in 24% of patients in group II, as compared to 8% 
of patients in group I, indicating that more patients 
had significant proteinuria in group II, correlating it 
with duration of disease (Table5).
Three patients presented with isolated haema-
turia in group I out of which two consented for renal 
biopsy, both patients had mesangial glomerulone-
phritis. Among two patients who presented with iso-
lated proteinuria, one showed membranous glom-
erulonephritis and the other had FSGS. One patient 
who had combined haematuria and proteinuria was 
having chronic interstitial nephritis.
In group II, three patients presented with iso-
lated haematuria, one patient who consented for bi-
opsy showed mesangial glomerulonephritis. Out of 
three patients who presented with isolated proteinu-
ria in group II, two patients had amyloidosis, while 
one  patient  had  membranous  glomerulonephritis. 
One patient who was having both haematuria and 
proteinuria in group II had chronic interstitial ne-
phritis. Therefore, all the patients having active uri-
nary sediment showed histopathological changes on 
renal biopsy (Table 4).
The mean DAS was 3.76±0.69 in group I and 
4.26±0.89  in  group  II.  The  comparison  of  DAS 
between  two  groups  was  statistically  significant 
(>Table 2). Severe DAS score was more apparent 
in patients with deranged renal functions. In group 
I, severe DAS score was present in 17% of patients 
with  urinary  abnormalities  and  20%  of  patients 
showing histopathological findings. While in group 
II, severe DAS score was present in 63% of patients 
with urinary abnormalities and 60% of patients with 
histopathological abnormality, thus indicating that 
severe DAS score was associated with significant 
effect on histofunctional status of kidney.(p<0.05) 
(Table 6).
Table 1. Sex Distribution
Group Male Female M : F ratio
Group I (n=25) 5 20 1 : 4
Group II (n=25) 3 22 1 : 7.3H.K. Aggarwal et al. Histofunctional status of kidney in rheumatoid arthritis 378
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Table 2. Biochemical parameters/renal parameters at baseline
Parameters  Group I (Mean±SD) Group II (Mean±SD) p value (unpaired)
Hemoglobin (gm%) 10.20±1.17 9.01±1.36 <0.001
Blood urea (mg%) 29.0±14.4 46.0±27.9 <0.01
S. Creatinine (mg%) 0.94±0.68 1.90±2.27 <0.05
Urine Output (ml/day) 1872±124 1730±432 NS
24 hour urine protein (g/l) 0.21±0.38 0.66±1.26 NS
24 hour urine creatinine (mg%) 84.92±11.19 76.96±15.92 <0.05
Creatinine clearance (ml/min)  104.8±27.0 90.3±46.8 <0.001
DAS * 3.76±0.69 4.26±0.89 <0.05
* Disability activity score. NS: Not significant
Table 3. Renal parameters
Group I (n=25) Group II (n=25) Total (n=50)
Parameters n %  n % n %
Blood urea (>40mg%) 1 4 6 24 7 14
Serum creatinine (>1.5mg%) 1 4 6 24 7 14
Table 4. Clinico-histopathological correlation
Urinary abnormalities Group II (n=25) Group II (n=25)
n
Biopsy
 performed
Renal
 lesion n
Biopsy
 performed Renal lesions
Isolated haematuria 3(12%) 2 MsGN (2) 3(12%) 1 MsGN (1)
Isolated proteinuria 2(8%) 2 MnGN (1)
 FSGS(1) 3(12%) 3 MnGN (1) Secondary
 amyloidosis (2)
Haematuria and proteinuria 1(4%) 1 CIN (1) 2(8%) 1 CIN (1)
MsGN, mesangial glomerulonephritis; MnGN, membranous glomerulonephritis;FSGS , focal segmental glomeruloscle-
rosis; CIN, chronic interstitial nephritis.
Table 5. Twenty-four hour urinary parameters
Parameters Group I (n=25) Group II (n=25) Total (n=50)
n %  n % n %
Total proteinuria (0.3 to 2.5gm/day) 2 8 6 24 8 16
Total proteinuria (>2.5gm/day) 2 8 4 16 6 12
GFR <90ml/min 1 4 6 24 7 14
Table 6. Renal parameters with DAS score
Group I (n=25) Group I (n=25) a
n severe DAS % n severe DAS % P value
Urine abnormalities 6 1 17 8 5 63 <0.05
Increased serum creatinine (>1.5mg%) 1 1 100 6 5 83 >0.05
Histopathological findings  5 1 20 5 3 60 <0.05H.K. Aggarwal et al. Histofunctional status of kidney in rheumatoid arthritis 379
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DISCUSSION
Renal involvement in connective tissue diseases like 
systemic lupus erythematosis (SLE) is well recogn-
ised. Affection of kidney in RA is more or less over-
looked and mainly attributed to drugs viz. Non ste-
roidal anti inflammatory drugs (NSAIDs) and Dis-
ease modifying anti rheumatic drugs (DMARD’s) 
like gold and d-penicillamine. Clinical manifesta-
tions of renal involvement in RA have been com-
monly attributed to secondary amyloidosis, usually 
associated with long time disease process.7
There is enough evidence that both functional 
abnormalities  and  histopathological  lesions  that 
may be attributed to disease itself do occur in RA 
patients.8-10 Boers et al classified renal disease into 
three categories- those due to RA and its compli-
cations, those related to drug therapy and a third 
category,  RA  nephropathy  due  to  disease  itself.11 
There is high prevalence of renal impairment with 
evidence of reduced glomerular filtration rate (GFR) 
and tubular function in RA patients. These patients 
are at risk of developing renal complications and 
proteinuria  which  increases  mortality  rate.12-14  In 
practice,  renal  involvement  usually  remains  un-
noticed for long period in a reversible subclinical 
stage and should therefore be detected as early as 
possible.11,15
In our study we observed that renal abnormali-
ties were quite prevalent in RA patients and there 
was significant increase of renal derangement with 
duration of disease and severity of disease activity. 
28% of patients in the present study showed urine 
abnormalities. Among them, isolated hematuria was 
persistent between groups whereas, isolated protei-
nuria and combined hematuria and proteinuria were 
more common in group II patients. The baseline re-
nal parameters i.e. hemoglobin, blood urea and se-
rum creatinine were significantly deranged in group 
II  than  in  group  I  patients,  thus  suggesting  that 
impairment of renal functions in the present study 
increased with duration of disease. Similar finding 
were observed by Pederson et al who studied 65 pa-
tients with RA for microalbuminuria and found that 
microalbuminuria was present in 27% of patients of 
RA, as against 7.8% of controls. A significant rela-
tion was noted between urinary albumin to creati-
nine ratio and CRP with the duration of disease.16 
Our findings are consistent with Sihvorien et al who 
studied 604 patients of RA and found isolated he-
maturia in 54 patients (8.9%), isolated proteinuria 
in 27 patients (4.5%) and combined hematuria and 
proteinuria in 7 patients (1.2%).17 
Similar findings were observed by Karstila et 
al who assessed the frequency of abnormal clinical 
renal findings in a population of 103 RA patients. 
In this study 9% patients had isolated hematuria, 
5% isolated proteinuria and 1% combined protei-
nuria  and  hematuria.18  Koseki  et  al  also  studied 
235 patients with early RA. They found 40 patients 
with hematuria and none had proteinuria. After 42 
months of follow up persistent hematuria was found 
in 43 patients (18%) and persistent proteinuria in 
17 patients (7%),19 thus signifying the importance 
of regular monitoring of renal functions in RA pa-
tients.  These  findings  are  in  agreement  with  the 
present study.
In the present study, renal biopsy was performed 
in 20% of patients who had renal abnormalities and 
consented for biopsy. The mesangial glomerulone-
phritis, characterized by mild mesangial hypercel-
lularity with or without a slight increase in mesan-
gial matrix & deposition of immunoglobulin and/
or complement components, was more common in 
group I patients, suggesting that it develops early 
in RA patients who present with isolated hematuria. 
These findings were similar to findings of Korpela 
et al. who found significant correlation between in-
tensity of IgA deposits and levels of IgM class rheu-
matoid factor.20 These findings emphasize that me-
sangial glomerulonephritis is related to basic rheu-
matoid disease and should be regarded as an extra 
articular manifestation of RA.
Membranous glomerulonephritis, diagnosed by 
histopathological  examination  showing  epimem-
branous spikes and granular subepithelial deposits, 
predominantly of IgG, was seen in one patient each 
in the two groups and both patients had isolated he-
maturia. The most common cause of membranous 
nephropathy  in  patients  with  RA  was  considered 
to be gold or penicillamine therapy in earlier days, 
however, many studies now highlight occurrence of 
membranous nephropathy even in patients of RA not 
been treated with gold or penicillamine.21,22 Second-
ary amyloidosis was present only in group II patients 
suggesting that secondary amyloidosis might occur 
with long duration of disease. Chronic interstitial 
nephritis was present in one patient each in the two 
groups. Our findings are consistent with Nakano et H.K. Aggarwal et al. Histofunctional status of kidney in rheumatoid arthritis 380
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al who studied renal biopsy in 158 RA patients with 
renal abnormalities. They found mesangial GN in 
54 patients, membranous GN in 49 and secondary 
amyloidosis in 30 patients.23 Helin et al also noted 
mesangial GN more commonly (40%) than amyloi-
dosis (33%) and membranous GN (19%) in patients 
with rheumatoid arthritis.24 Korpela et al evaluated 
1018 patients of RA for presence of isolated hema-
turia and histopathological changes in them. They 
reported mesangial glomerulopathy was the most 
common renal biopsy finding in RA patients with 
isolated hematuria.20
Boers et al studied 132 biopsies of RA patients 
with renal abnormalities and/or renal dysfunctions 
and  they  found  secondary  amyloidosis  occurring 
with long duration of disease which was accompa-
nied by proteinuria and uremia.11
We  also  tried  to  correlate  renal  dysfunction 
with severity of DAS score. The mean DAS score 
value was significantly higher in group II patients 
than in group I. In the present study,the RA patients 
with urine abnormalities and histopathological find-
ings showed severe DAS score, thus suggesting that 
severity of DAS increased with duration of disease 
and renal involvement was more common in RA pa-
tients with severe DAS score.
The clinicohistopathological correlation of re-
nal involvement in RA patients is less clearly under-
stood and without doubt heterogenous. Secondary 
amyloidosis results from deposition of fibril con-
taining AA protein which is antigenetically related 
to serum amyloid A(SAA) protein. SAA protein is 
increased up to 10000fold by inflammatory stimuli 
in RA.7 Similarly there is a striking association of 
IgM  rheumatoid  factor  with  mesangial  glomeru-
lonephritis. There occurs a functional response of 
renal mesangium to remove IgM rheumatoid factor 
immunoglobulin G complex which leads to mesan-
gial lesions.20
The  present  observations,  albeit  with  limita-
tion of small sample size, reveal that renal functions 
were significantly deranged in patients of rheuma-
toid arthritis, which may remain unnoticed at sub-
clinical level if renal parameters are not monitored 
at regular basis. Although various biomarkers like 
urinary alfa-1 microglobulin estimation, urinary n-
acetly glycosaminidase (NAG) and cystatin-c levels 
for glomerular and/or tubular proteinuria and GFR 
estimation are available, histopathology remains the 
gold standard to diagnose RA nephropathy.15 There-
fore the observations of the present study reveals 
that showed that RA patients should be routinely 
subjected  to  renal  function  tests  and  if  required, 
renal  biopsy  may  be  considered  in  patients  hav-
ing urinary abnormalities and/or renal dysfunction 
to understand the histofunctional status of kidney. 
This approach will further help in dose modifica-
tion of DMARD’s and various other drugs used for 
the treatment of rheumatoid arthritis in this group 
of patients.
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